CD274 and neoplasm: Moreover, TEX-bound PD-L1 can inhibit T-cell-mediated immunity and enhance tumor growth in different tumor types, including lung [67], breast [64], prostate [65], head and neck [58,59], oral-oesophageal [71], and gastric cancers [69] (Figure 2).